{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:52:50Z","timestamp":1782280370307,"version":"3.54.5"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["#212176"],"award-info":[{"award-number":["#212176"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-036442"],"award-info":[{"award-number":["INV-036442"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The identification of genetic markers has revolutionized the assessment of antimalarial drug resistance. Tracking the molecular markers of resistance emerged as a valuable tool over 60\u00a0years ago, following the identification of sulfadoxine-pyrimethamine (SP) genetic resistance markers,\n                    <jats:italic>dhfr<\/jats:italic>\n                    and\n                    <jats:italic>dhps.<\/jats:italic>\n                    The Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines were used. PubMed\/MEDLINE, Embase, Scopus, Google Scholar and Web of Science were systematically searched to identify studies on antimalarial drug resistance markers in Kenya published in English between 01-Jan-1995 and 31-Oct-2024. The national analysis showed a regional shift in the timelines from the mutant to wild-type\n                    <jats:italic>crt<\/jats:italic>\n                    genotype and similarly from the mutant (CVIET) to wild-type (CVMNK) microhaplotype, with the Coast occurring earlier in 2002, while Western Kenya the change occurred later in 2008. MDR1 codons 86 and 1246, also genetic markers of chloroquine resistance have shown a full reversion to the wildtype, that was rising since 1994 in the Coast and 2003 in Western Kenya. By the time drug policy changed to SP in 1999 the\n                    <jats:italic>dhps<\/jats:italic>\n                    mutant genotype was already rising from 1996 in the Coast and 1998 from Western Kenya, while the\n                    <jats:italic>dhfr<\/jats:italic>\n                    codon 108 shift to mutant occurred as early as 1988 in the Coastal parasite populations. The World Health Organization-validated\n                    <jats:italic>k13<\/jats:italic>\n                    mutations were first described, P553L, in 2006 in Kisumu. This aggregation of data across Kenya demonstrates the utility of this scoping review. The compilation and standardization of over 100 studies provides a high-level, structured overview of when and where resistance markers have been surveyed. This establishes a foundational national repository to support strategic surveillance planning by the Kenya NMCP.\n                  <\/jats:p>","DOI":"10.1186\/s12936-025-05616-y","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T09:53:35Z","timestamp":1763546015000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A scoping review of antimalarial drug resistance markers in Kenya (1987\u20132022): toward a National Surveillance Framework and Data Repository"],"prefix":"10.1186","volume":"24","author":[{"given":"Kevin","family":"Wamae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Magudha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Asiimwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kariuki","family":"Kimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Kandie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kibor","family":"Keitany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Snow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Isabella","family":"Ochola-Oyier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"5616_CR1","unstructured":"WHO. Global report on antimalarial drug efficacy and drug resistance: 2000\u20132010. Geneva: World Health Organization."},{"key":"5616_CR2","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nature00813","volume":"418","author":"JC Wootton","year":"2002","unstructured":"Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, et al. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature. 2002;418:320\u20133.","journal-title":"Nature"},{"key":"5616_CR3","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1126\/science.1098876","volume":"305","author":"C Roper","year":"2004","unstructured":"Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T. Intercontinental spread of pyrimethamine-resistant malaria. Science. 2004;305:1124.","journal-title":"Science"},{"key":"5616_CR4","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1093\/infdis\/jir664","volume":"204","author":"T Mita","year":"2011","unstructured":"Mita T, Venkatesan M, Ohashi J, Culleton R, Takahashi N, Tsukahara T, et al. Limited geographical origin and global spread of sulfadoxine-resistant dhps alleles in Plasmodium falciparum populations. J Infect Dis. 2011;204:1980\u20138.","journal-title":"J Infect Dis"},{"key":"5616_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"5616_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.08714","volume":"5","author":"MalariaGEN Plasmodium falciparum community project","year":"2016","unstructured":"MalariaGEN Plasmodium falciparum community project. Genomic epidemiology of artemisinin resistant malaria. Elife. 2016;5:1\u201329.","journal-title":"Elife"},{"key":"5616_CR7","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","volume":"374","author":"D M\u00e9nard","year":"2016","unstructured":"M\u00e9nard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, et al. A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N Engl J Med. 2016;374:2453\u201364.","journal-title":"N Engl J Med"},{"key":"5616_CR8","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0764-4469(98)80009-7","volume":"321","author":"J-F Trape","year":"1998","unstructured":"Trape J-F, Pison G, Preziosi M-P, Enel C, du Lo\u00fb AD, Delaunay V, et al. Impact of chloroquine resistance on malaria mortality. CR Acad Sci III. 1998;321:689\u201397.","journal-title":"CR Acad Sci III"},{"key":"5616_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1473-3099(03)00657-1","volume":"3","author":"EL Korenromp","year":"2003","unstructured":"Korenromp EL, Williams BG, Gouws E, Dye C, Snow RW. Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. Lancet Infect Dis. 2003;3:349\u201358.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"5616_CR10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jiph.2022.03.015","volume":"15","author":"BJ Njiro","year":"2022","unstructured":"Njiro BJ, Mutagonda RF, Chamani AT, Mwakyandile T, Sabas D, Bwire GM. Molecular surveillance of chloroquine-resistant Plasmodium falciparum in sub-Saharan African countries after withdrawal of chloroquine for treatment of uncomplicated malaria: a systematic review. J Infect Public Health. 2022;15(5):550\u20137.","journal-title":"J Infect Public Health"},{"key":"5616_CR11","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/s41564-023-01461-4","volume":"8","author":"AA Fola","year":"2023","unstructured":"Fola AA, Feleke SM, Mohammed H, Brhane BG, Hennelly CM, Assefa A, et al. Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia. Nat Microbiol. 2023;8:1911\u20139.","journal-title":"Nat Microbiol"},{"key":"5616_CR12","doi-asserted-by":"publisher","first-page":"7389","DOI":"10.1038\/s41598-017-06708-9","volume":"7","author":"LC Okell","year":"2017","unstructured":"Okell LC, Griffin JT, Roper C. Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa. Sci Rep. 2017;7:7389.","journal-title":"Sci Rep"},{"key":"5616_CR13","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1475-2875-13-152","volume":"13","author":"SI Matondo","year":"2014","unstructured":"Matondo SI, Temba GS, Kavishe AA, Kauki JS, Kalinga A, Van Zwetselaar M, et al. High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania. Malar J. 2014;13:152.","journal-title":"Malar J"},{"key":"5616_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.pt.2013.08.002","volume":"29","author":"I Naidoo","year":"2013","unstructured":"Naidoo I, Roper C. Mapping \u2018partially resistant\u2019, \u2018fully resistant\u2019, and \u2018super resistant\u2019 malaria. Trends Parasitol. 2013;29:505\u201315.","journal-title":"Trends Parasitol"},{"key":"5616_CR15","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1056\/NEJMc0805011","volume":"359","author":"H Noedl","year":"2008","unstructured":"Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, et al. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359:2619\u201320.","journal-title":"N Engl J Med"},{"key":"5616_CR16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455\u201367.","journal-title":"N Engl J Med"},{"key":"5616_CR17","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","volume":"26","author":"A Uwimana","year":"2020","unstructured":"Uwimana A, Legrand E, Stokes BH, Ndikumana J-LM, Warsame M, Umulisa N, et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat Med. 2020;26:1602\u20138.","journal-title":"Nat Med"},{"key":"5616_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijpddr.2021.06.001","volume":"16","author":"L Ndwiga","year":"2021","unstructured":"Ndwiga L, Kimenyi KM, Wamae K, Osoti V, Akinyi M, Omedo I, et al. A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa. Int J Parasitol Drugs Drug Resist. 2021;16:155\u201361.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5616_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3347\/PHD.24053","volume":"63","author":"SA Oyegbade","year":"2025","unstructured":"Oyegbade SA, Mameh EO, Balogun DO, Aririguzoh VGO, Akinduti PA. Emerging Plasmodium falciparum k13 gene mutation to artemisinin-based combination therapies and partner drugs among malaria-infected population in sub-Saharan Africa. Parasit Hosts Dis. 2025;63:109.","journal-title":"Parasit Hosts Dis"},{"key":"5616_CR20","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1128\/AAC.44.4.991-996.2000","volume":"44","author":"AM Nzila","year":"2000","unstructured":"Nzila AM, Mberu EK, Sulo J, Dayo H, Winstanley PA, Sibley CH, et al. Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites. Antimicrob Agents Chemother. 2000;44:991\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"5616_CR21","doi-asserted-by":"publisher","unstructured":"WHO. Guidelines for malaria. Geneva: World Health Organization; 2024. https:\/\/doi.org\/10.2471\/B09146. Licence: CC BY-NC-SA 3.0 IGO. Accessed 30 Nov 2024.","DOI":"10.2471\/B09146"},{"key":"5616_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12936-019-2853-4","volume":"18","author":"DS Ishengoma","year":"2019","unstructured":"Ishengoma DS, Saidi Q, Sibley CH, Roper C, Alifrangis M. Deployment and utilization of next-generation sequencing of Plasmodium falciparum to guide anti-malarial drug policy decisions in sub-Saharan Africa: opportunities and challenges. Malar J. 2019;18:267.","journal-title":"Malar J"},{"key":"5616_CR23","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.1038\/s41467-025-59946-1","volume":"16","author":"V Wasakul","year":"2025","unstructured":"Wasakul V, Verschuuren TD, Thuy-Nhien N, Booth E, Quang HH, Thang ND, et al. Genetic surveillance of Plasmodium falciparum populations following treatment policy revisions in the Greater Mekong Subregion. Nat Commun. 2025;16:4689.","journal-title":"Nat Commun"},{"key":"5616_CR24","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12936-018-2489-9","volume":"17","author":"PM Macharia","year":"2018","unstructured":"Macharia PM, Giorgi E, Noor AM, Waqo E, Kiptui R, Okiro EA, et al. Spatio-temporal analysis of Plasmodium falciparum prevalence to understand the past and chart the future of malaria control in Kenya. Malar J. 2018;17:340.","journal-title":"Malar J"},{"issue":"12","key":"5616_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0000014","volume":"1","author":"VA Alegana","year":"2021","unstructured":"Alegana VA, Macharia PM, Muchiri S, Mumo E, Oyugi E, Kamau A, et al. Plasmodium falciparum parasite prevalence in East Africa: updating data for malaria stratification. PLoS Glob Public Health. 2021;1(12):e0000014.","journal-title":"PLoS Glob Public Health"},{"key":"5616_CR26","volume-title":"Kenya Malaria Strategy 2019\u20132023","author":"National Malaria Control Programme and Ministry of Health","year":"2015","unstructured":"National Malaria Control Programme and Ministry of Health. Kenya Malaria Strategy 2019\u20132023. Nairobi: National Malaria Control Programme and Ministry of Health; 2015."},{"key":"5616_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/0035-9203(79)90220-7","volume":"73","author":"S Fogh","year":"1979","unstructured":"Fogh S, Jepsen S, Effers\u00f8e P. Chloroquine-resistant Plasmodium falciparum malaria in Kenya. Trans R Soc Trop Med Hyg. 1979;73:228\u20139.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5616_CR28","doi-asserted-by":"publisher","first-page":"902","DOI":"10.4269\/ajtmh.1982.31.902","volume":"31","author":"HC Spencer","year":"1982","unstructured":"Spencer HC, Masaba SC, Kiaraho D. Sensitivity of Plasmodium falciparum isolates to chloroquine in Kisumu and Malindi, Kenya. Am J Trop Med Hyg. 1982;31:902\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"5616_CR29","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1046\/j.1365-3156.2000.00643.x","volume":"5","author":"R Shretta","year":"2000","unstructured":"Shretta R, Omumbo J, Rapuoda B, Snow RW. Using evidence to change antimalarial drug policy in Kenya. Trop Med Int Health. 2000;5:755\u201364.","journal-title":"Trop Med Int Health"},{"key":"5616_CR30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1475-2875-6-72","volume":"6","author":"AA Amin","year":"2007","unstructured":"Amin AA, Zurovac D, Kangwana BB, Greenfield J, Otieno DN, Akhwale WS, et al. The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya. Malar J. 2007;6:72.","journal-title":"Malar J"},{"key":"5616_CR31","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1046\/j.1365-3156.2001.00799.x","volume":"6","author":"EANMAT","year":"2001","unstructured":"EANMAT. Monitoring antimalarial drug resistance within National Malaria Control Programmes: the EANMAT experience. Trop Med Int Health. 2001;6:891\u20138.","journal-title":"Trop Med Int Health."},{"key":"5616_CR32","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1046\/j.1360-2276.2003.01114.x","volume":"8","author":"B Rapuoda","year":"2003","unstructured":"Rapuoda B, Ali A, Bakyaita N, Mutabingwa TK, Mwita A, Rwagacondo C, et al. The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: Implications for sub-regional policy. Trop Med Int Health. 2003;8:860\u20137.","journal-title":"Trop Med Int Health"},{"key":"5616_CR33","doi-asserted-by":"publisher","DOI":"10.3201\/eid2313.170366","volume":"23","author":"ES Halsey","year":"2017","unstructured":"Halsey ES, Venkatesan M, Plucinski MM, Talundzic E, Lucchi NW, Zhou Z, et al. Capacity development through the US president\u2019s malaria initiative\u2013supported antimalarial resistance monitoring in Africa network. Emerg Infect Dis. 2017;23:S53\u20136.","journal-title":"Emerg Infect Dis"},{"key":"5616_CR34","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467\u201373.","journal-title":"Ann Intern Med"},{"key":"5616_CR35","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev. 2016;5:210.","journal-title":"Syst Rev"},{"key":"5616_CR36","doi-asserted-by":"publisher","first-page":"D539","DOI":"10.1093\/nar\/gkn814","volume":"37","author":"C Aurrecoechea","year":"2009","unstructured":"Aurrecoechea C, Brestelli J, Brunk BP, Dommer J, Fischer S, Gajria B, et al. PlasmoDB: a functional genomic database for malaria parasites. Nucleic Acids Res. 2009;37:D539\u201343.","journal-title":"Nucleic Acids Res"},{"key":"5616_CR37","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/nar\/gkg081","volume":"31","author":"A Bahl","year":"2003","unstructured":"Bahl A, Brunk B, Crabtree J, Fraunholz MJ, Gajria B, Grant GR, et al. PlasmoDB: the Plasmodium genome resource. A database integrating experimental and computational data. Nucleic Acids Res. 2003;31:212\u20135.","journal-title":"Nucleic Acids Res."},{"key":"5616_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12936-023-04812-y","volume":"23","author":"B Jeang","year":"2024","unstructured":"Jeang B, Zhong D, Lee M-C, Atieli H, Yewhalaw D, Yan G. Molecular surveillance of Kelch 13 polymorphisms in Plasmodium falciparum isolates from Kenya and Ethiopia. Malar J. 2024;23:36.","journal-title":"Malar J"},{"key":"5616_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s41182-024-00640-1","volume":"52","author":"M Makau","year":"2024","unstructured":"Makau M, Kanoi BN, Mgawe C, Maina M, Bitshi M, Too EK, et al. Presence of Plasmodium falciparum strains with artemisinin-resistant k13 mutation C469Y in Busia County, Western Kenya. Trop Med Health. 2024;52:72.","journal-title":"Trop Med Health"},{"key":"5616_CR40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12879-025-10462-z","volume":"25","author":"V Osoti","year":"2025","unstructured":"Osoti V, Wamae K, Ndwiga L, Gichuki PM, Okoyo C, Kepha S, et al. Detection of low frequency artemisinin resistance mutations, C469Y, P553L and A675V, and fixed antifolate resistance mutations in asymptomatic primary school children in Kenya. BMC Infect Dis. 2025;25:73.","journal-title":"BMC Infect Dis"},{"key":"5616_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12936-023-04517-2","volume":"22","author":"JN Maniga","year":"2023","unstructured":"Maniga JN, Samuel M, John O, Rael M, Muchiri JN, Bwogo P, et al. Novel Plasmodium falciparum k13 gene polymorphisms from Kisii County, Kenya during an era of artemisinin-based combination therapy deployment. Malar J. 2023;22:87.","journal-title":"Malar J"},{"key":"5616_CR42","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/infdis\/jiu467","volume":"211","author":"SM Taylor","year":"2015","unstructured":"Taylor SM, Parobek CM, DeConti DK, Kayentao K, Coulibaly SO, Greenwood BM, et al. Absence of putative artemisinin resistance mutations among Plasmodium falciparum in sub-Saharan Africa: a molecular epidemiologic study. J Infect Dis. 2015;211:680\u20138.","journal-title":"J Infect Dis"},{"key":"5616_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.12688\/wellcomeopenres.17656.1","volume":"7","author":"I Omedo","year":"2022","unstructured":"Omedo I, Bartilol B, Kimani D, Gon\u00e7alves S, Drury E, Rono MK, et al. Spatio-temporal distribution of antimalarial drug resistant gene mutations in a Plasmodium falciparum parasite population from Kilifi, Kenya: a 25-year retrospective study. Wellc Open Res. 2022;7:45.","journal-title":"Wellc Open Res"},{"key":"5616_CR44","first-page":"1","volume":"3099","author":"AM van Eijk","year":"2019","unstructured":"van Eijk AM, Larsen DA, Kayentao K, Koshy G, Slaughter DEC, Roper C, et al. Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis. Lancet Infect Dis. 2019;3099:1\u201311.","journal-title":"Lancet Infect Dis"},{"key":"5616_CR45","doi-asserted-by":"publisher","first-page":"9862","DOI":"10.1021\/bi050061f","volume":"44","author":"CP Sanchez","year":"2005","unstructured":"Sanchez CP, McLean JE, Rohrbach P, Fidock DA, Stein WD, Lanzer M. Evidence for a Pfcrt-associated chloroquine efflux system in the human malarial parasite Plasmodium falciparum. Biochemistry. 2005;44:9862\u201370.","journal-title":"Biochemistry"},{"key":"5616_CR46","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.actatropica.2005.04.008","volume":"94","author":"MT Duraisingh","year":"2005","unstructured":"Duraisingh MT, Cowman AF. Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop. 2005;94:181\u201390.","journal-title":"Acta Trop"},{"key":"5616_CR47","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","volume":"6","author":"DA Fidock","year":"2000","unstructured":"Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell. 2000;6:861\u201371.","journal-title":"Mol Cell"},{"key":"5616_CR48","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1046\/j.1365-2958.2000.01914.x","volume":"36","author":"MT Duraisingh","year":"2000","unstructured":"Duraisingh MT, Roper C, Walliker D, Warhurst DC. Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Mol Microbiol. 2000;36:955\u201361.","journal-title":"Mol Microbiol"},{"key":"5616_CR49","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/35002615","volume":"403","author":"MB Reed","year":"2000","unstructured":"Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature. 2000;403:906\u20139.","journal-title":"Nature"},{"key":"5616_CR50","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1128\/AAC.00638-09","volume":"53","author":"L Mwai","year":"2009","unstructured":"Mwai L, Kiara SM, Abdirahman A, Pole L, Rippert A, Diriye A, et al. In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. Antimicrob Agents Chemother. 2009;53:5069\u201373.","journal-title":"Antimicrob Agents Chemother"},{"key":"5616_CR51","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1128\/AAC.47.8.2418-2423.2003","volume":"47","author":"AL Pickard","year":"2003","unstructured":"Pickard AL, Wongsrichanalai C, Purfield A, Kamwendo D, Emery K, Zalewski C, et al. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Antimicrob Agents Chemother. 2003;47:2418\u201323.","journal-title":"Antimicrob Agents Chemother"},{"key":"5616_CR52","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/j.1365-2958.2005.04729.x","volume":"57","author":"ABS Sidhu","year":"2005","unstructured":"Sidhu ABS, Valderramos SG, Fidock DA. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol Microbiol. 2005;57:913\u201326.","journal-title":"Mol Microbiol."},{"key":"5616_CR53","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1086\/507115","volume":"194","author":"ABS Sidhu","year":"2006","unstructured":"Sidhu ABS, Uhlemann A-C, Valderramos SG, Valderramos J-C, Krishna S, Fidock DA. Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J Infect Dis. 2006;194:528\u201335.","journal-title":"J Infect Dis"},{"key":"5616_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(20)30117-8","volume":"1","author":"SK Tessema","year":"2020","unstructured":"Tessema SK, Inzaule SC, Christoffels A, Kebede Y, de Oliveira T, Ouma AEO, et al. Accelerating genomics-based surveillance for COVID-19 response in Africa. Lancet Microbe. 2020;1:e227\u20138.","journal-title":"Lancet Microbe"},{"key":"5616_CR55","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s12936-020-03479-z","volume":"19","author":"B Amboko","year":"2020","unstructured":"Amboko B, Stepniewska K, Macharia PM, Machini B, Bejon P, Snow RW, et al. Trends in health workers\u2019 compliance with outpatient malaria case-management guidelines across malaria epidemiological zones in Kenya, 2010\u20132016. Malar J. 2020;19:406.","journal-title":"Malar J"},{"key":"5616_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/cl2.1230","volume":"18","author":"NR Haddaway","year":"2022","unstructured":"Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis. Campbell Syst Rev. 2022;18:e1230.","journal-title":"Campbell Syst Rev"},{"key":"5616_CR57","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJM200101253440403","volume":"344","author":"A Djimd\u00e9","year":"2001","unstructured":"Djimd\u00e9 A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourt\u00e9 Y, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med. 2001;344:257\u201363.","journal-title":"N Engl J Med"},{"key":"5616_CR58","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1126\/science.1074045","volume":"298","author":"ABS Sidhu","year":"2002","unstructured":"Sidhu ABS, Verdier-Pinard D, Fidock DA. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science. 2002;298:210\u20133.","journal-title":"Science"},{"key":"5616_CR59","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/345255a0","volume":"345","author":"SJ Foote","year":"1990","unstructured":"Foote SJ, Kyle DE, Martin RK, Oduola AMJ, Forsyth K, Kemp DJ, et al. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature. 1990;345:255\u20138.","journal-title":"Nature"},{"key":"5616_CR60","doi-asserted-by":"publisher","first-page":"9114","DOI":"10.1073\/pnas.85.23.9114","volume":"85","author":"DS Peterson","year":"1988","unstructured":"Peterson DS, Walliker D, Wellems TE. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci USA. 1988;85:9114\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5616_CR61","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1073\/pnas.87.8.3014","volume":"87","author":"SJ Foote","year":"1990","unstructured":"Foote SJ, Galatis D, Cowman AF. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc Natl Acad Sci USA. 1990;87:3014\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5616_CR62","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0166-6851(94)00207-4","volume":"69","author":"LK Basco","year":"1995","unstructured":"Basco LK, de P\u00e9coulas PE, Wilson CM, Le Bras J, Mazabraud A. Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol Biochem Parasitol. 1995;69:135\u20138.","journal-title":"Mol Biochem Parasitol"},{"key":"5616_CR63","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1093\/emboj\/17.14.3807","volume":"17","author":"T Triglia","year":"1998","unstructured":"Triglia T, Wang P, Sims PFG, Hyde JE, Cowman AF. Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria. EMBO J. 1998;17:3807\u201315.","journal-title":"EMBO J"},{"key":"5616_CR64","unstructured":"WHO. Artemisinin resistance and artemisinin-based combination therapy efficacy. Geneva: World Health Organization; 2018. https:\/\/www.who.int\/malaria\/publications\/atoz\/artemisinin-resistance-august2018\/en\/."},{"key":"5616_CR65","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1473-3099(16)30415-7","volume":"17","author":"B Witkowski","year":"2017","unstructured":"Witkowski B, Duru V, Khim N, Ross LS, Saintpierre B, Beghain J, et al. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype\u2013genotype association study. Lancet Infect Dis. 2017;17:174\u201383.","journal-title":"Lancet Infect Dis"},{"key":"5616_CR66","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/s41467-018-04104-z","volume":"9","author":"S Bopp","year":"2018","unstructured":"Bopp S, Magistrado P, Wong W, Schaffner SF, Mukherjee A, Lim P, et al. Plasmepsin II\u2013III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum. Nat Commun. 2018;9:1769.","journal-title":"Nat Commun"},{"key":"5616_CR67","doi-asserted-by":"publisher","first-page":"12799","DOI":"10.1073\/pnas.1812317115","volume":"115","author":"AR Demas","year":"2018","unstructured":"Demas AR, Sharma AI, Wong W, Early AM, Redmond S, Bopp S, et al. Mutations in Plasmodium falciparum actin-binding protein coronin confer reduced artemisinin susceptibility. Proc Natl Acad Sci USA. 2018;115:12799\u2013804.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5616_CR68","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1086\/606009","volume":"200","author":"S Dahlstr\u00f6m","year":"2009","unstructured":"Dahlstr\u00f6m S, Ferreira PE, Veiga MI, Sedighi N, Wiklund L, M\u00e5rtensson A, et al. Plasmodium falciparum multidrug resistance protein 1 and artemisinin-based combination therapy in Africa. J Infect Dis. 2009;200:1456\u201364.","journal-title":"J Infect Dis"},{"key":"5616_CR69","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1093\/infdis\/jiu358","volume":"210","author":"G Henriques","year":"2014","unstructured":"Henriques G, Hallett RL, Beshir KB, Gadalla NB, Johnson RE, Burrow R, et al. Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT. J Infect Dis. 2014;210:2001\u20138.","journal-title":"J Infect Dis"},{"key":"5616_CR70","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1818287115","author":"RC Henrici","year":"2018","unstructured":"Henrici RC, Sutherland CJ. Alternative pathway to reduced artemisinin susceptibility in Plasmodium falciparum. Proc Natl Acad Sci USA. 2018. https:\/\/doi.org\/10.1073\/pnas.1818287115.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5616_CR71","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S1473-3099(16)30409-1","volume":"17","author":"R Amato","year":"2017","unstructured":"Amato R, Lim P, Miotto O, Amaratunga C, Dek D, Pearson RD, et al. Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study. Lancet Infect Dis. 2017;17:164\u201373.","journal-title":"Lancet Infect Dis"},{"key":"5616_CR72","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/S0140-6736(05)67787-2","volume":"366","author":"R Jambou","year":"2005","unstructured":"Jambou R, Legrand E, Niang M, Khim N. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet. 2005;366:1960\u20133.","journal-title":"Lancet"},{"key":"5616_CR73","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1475-2875-11-131","volume":"11","author":"DR Pillai","year":"2012","unstructured":"Pillai DR, Lau R, Khairnar K, Lepore R, Via A, Staines HM, et al. Artemether resistance in vitro is linked to mutations in PfATP6 that also interact with mutations in PfMDR1 in travellers returning with Plasmodium falciparum infections. Malar J. 2012;11:131.","journal-title":"Malar J"},{"key":"5616_CR74","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A-C, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135.","journal-title":"Nature"},{"key":"5616_CR75","doi-asserted-by":"publisher","first-page":"9687","DOI":"10.1038\/s41598-018-28017-5","volume":"8","author":"A Amambua-Ngwa","year":"2018","unstructured":"Amambua-Ngwa A, Jeffries D, Amato R, Worwui A, Karim M, Ceesay S, et al. Consistent signatures of selection from genomic analysis of pairs of temporal and spatial Plasmodium falciparum populations from The Gambia. Sci Rep. 2018;8:9687.","journal-title":"Sci Rep"},{"key":"5616_CR76","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ng.3189","volume":"47","author":"O Miotto","year":"2015","unstructured":"Miotto O, Amato R, Ashley EA, MacInnis B, Almagro-Garcia J, Amaratunga C, et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat Genet. 2015;47:226\u201334.","journal-title":"Nat Genet"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05616-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05616-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05616-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T11:03:27Z","timestamp":1763550207000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05616-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5616"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05616-y","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read the final version and agree to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"413"}}